What is the function of il13?
In the lung, IL-13 is the central mediator of allergic asthma, where it regulates eosinophilic inflammation, mucus secretion, and airway hyperresponsiveness.
Which interleukin inhibits the immune response?
Interleukin 13 (IL-13) is a pleiotropic cytokine that may be important in the regulation of the inflammatory and immune responses. It inhibits inflammatory cytokine production and synergises with IL-2 in regulating interferon-gamma synthesis.
Is IL-13 antiinflammatory?
From these observations, it can be concluded that IL-13 is an antiinflammatory cytokine that plays a unique role in the induction and maintenance of IgE production and IgE-mediated allergic responses.
What do the different interleukins do?
Interleukins regulate cell growth, differentiation, and motility. They are particularly important in stimulating immune responses, such as inflammation. Interleukins are a subset of a larger group of cellular messenger molecules called cytokines, which are modulators of cellular behaviour.
What are interleukins in immunology?
Introduction. Interleukins (IL) are a type of cytokine first thought to be expressed by leukocytes alone but have later been found to be produced by many other body cells. They play essential roles in the activation and differentiation of immune cells, as well as proliferation, maturation, migration, and adhesion.
What are the types of interleukins?
Function
- Interleukin-1 (IL-1) Macrophages, large granular lymphocytes, B cells, endothelium, fibroblasts, and astrocytes secrete IL-1.
- Interleukin-2 (IL-2) T cells produce IL-2.
- Interleukin-3 (IL-3)
- Interleukin-4 (IL-4)
- Interleukin-5 (IL-5)
- Interleukin-6 (IL-6)
- Interleukin-7 (IL-7)
- Interleukin-8 (IL-8)
What biologic is IL-12 23?
TNFα inhibitors, such as the fusion protein etanercept (Enbrel) and the monoclonal antibodies adalimumab (Humira) and infliximab (Remicade), make up the first class of biologic agents. The next class to be approved by the Food and Drug Administration (FDA) was the monoclonal antibody ustekinumab, an IL-12/23 inhibitor.